Long-Term Cardiovascular Effects of Medications for Attention-Deficit/Hyperactivity Disorder-Balancing Benefits and Risks of Treatment

JAMA Psychiatry. 2024 Feb 1;81(2):123-124. doi: 10.1001/jamapsychiatry.2023.4126.
No abstract available

MeSH terms

  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Blood Pressure
  • Central Nervous System Stimulants* / therapeutic use
  • Humans
  • Risk Assessment

Substances

  • Central Nervous System Stimulants